FDA Inspection
Amandeep Salhotra, M.D.Amandeep Salhotra, M.D. – FDA Inspection, May 2, 2024
Record Details
This FDA Inspection record concerns Amandeep Salhotra, M.D., with an inspection on May 2, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · e9707617-0fde-4e8b-a5cf-2ab3aafba0a1
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1238448
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
2- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Amandeep Salhotra, M.D.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| December 4, 2025 | VAI | Los Angeles District Office | Human Cellular, Tissue, and Gene Therapies |
Other documents for Amandeep Salhotra, M.D.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.